Results 181 to 190 of about 3,345,035 (259)
Spatio-temporal patterns of river water quality in the klang river basin, malaysia: a functional data analysis approach to detect pre- and post-pandemic shifts. [PDF]
Ali NFM, Mohamed I, Yunus RM, Othman F.
europepmc +1 more source
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim +3 more
wiley +1 more source
Condition monitoring and multi-fault classification of hydraulic systems using multivariate functional data analysis. [PDF]
Yildirim C, Franco-Pereira AM, Lillo RE.
europepmc +1 more source
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller +10 more
wiley +1 more source
mxfda: a comprehensive toolkit for functional data analysis of single-cell spatial data. [PDF]
Wrobel J +6 more
europepmc +1 more source
Human L1 Transposition Dynamics Unraveled with Functional Data Analysis. [PDF]
Chen D +5 more
europepmc +1 more source
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur +11 more
wiley +1 more source
Raw-Data Driven Functional Data Analysis with Multi-Adaptive Functional Neural Networks for Ergonomic Risk Classification Using Facial and Bio-Signal Time-Series Data. [PDF]
Kim S +4 more
europepmc +1 more source
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq +8 more
wiley +1 more source

